Skip to Content

Join the 'Betamethasone / Calcipotriene' group to help and get support from people like you.

Betamethasone / Calcipotriene News

Severe Psoriasis May Make Diabetes Increasingly Likely

Posted 20 Nov 2017 by Drugs.com

MONDAY, Nov. 20, 2017 – People with the skin disease psoriasis are at increased risk for type 2 diabetes, and the more severe the psoriasis, the greater their risk, a new study finds. Researchers examined data on nearly 85,000 adults in the United Kingdom, including 8,100 who had psoriasis. Compared with people who did not have psoriasis, the risk for diabetes was 21 percent higher among those with psoriasis on 2 percent or less of their body. It was 64 percent higher among those with psoriasis on more than 10 percent of their body. For every 10 percent increase in body area with psoriasis, the risk for diabetes rose another 20 percent. For instance, people with psoriasis on 20 percent of their body had a nearly 84 percent increased risk for diabetes. And those with psoriasis on 30 percent of their body had a 104 percent increased risk, the study authors said. When applying their ... Read more

Related support groups: Diabetes, Type 2, Methotrexate, Psoriasis, Plaque Psoriasis, Tazorac, Dovonex, Soriatane, Taclonex, Acitretin, Calcipotriene, Resorcinol, Enstilar, Vectical, Oxsoralen, Anthralin, Oxsoralen-Ultra, Drithocreme, Methotrexate LPF Sodium, Methoxsalen, Tazarotene

Cyndi Lauper's Psoriasis Battle Shows Her 'True Colors'

Posted 25 Oct 2017 by Drugs.com

WEDNESDAY, Oct. 25, 2017 – With her pink tresses and eye-catching stage costumes, pop culture icon Cyndi Lauper was never one to hide. But that's exactly what she wanted to do when she developed psoriasis, which spread to most of her body and sapped her strength before the skin disorder was controlled. Appearing first on her scalp and later covering everything except her face, psoriasis struck Lauper in 2010 while the Grammy, Tony and Emmy award-winning singer-songwriter – famous for 1980s' hits such as "Girls Just Want to Have Fun" and "Time After Time" – was on tour. She soldiered through appearances despite crushing exhaustion and an inability to regulate her temperature, which left her zigzagging between hot and cold. "It's funny – you start wearing gloves, or this and that, hoping that [psoriasis] is invisible, but it's not. I wasn't wearing it like, 'Woo-hoo, check this out!' ... Read more

Related support groups: Skin Rash, Methotrexate, Psoriasis, Plaque Psoriasis, Tazorac, Dovonex, Soriatane, Taclonex, Acitretin, Calcipotriene, Resorcinol, Enstilar, Vectical, Oxsoralen, Anthralin, Oxsoralen-Ultra, Drithocreme, Methotrexate LPF Sodium, Methoxsalen, Tazarotene

Severe Psoriasis Linked to Higher Risk of Earlier Death

Posted 5 Sep 2017 by Drugs.com

TUESDAY, Sept. 5, 2017 – People with severe cases of the skin disease psoriasis appeared to have almost double the risk of dying during a four-year study than people without the condition, research suggests. But the increased death rate was only seen in those with psoriasis affecting more than 10 percent of their body surface area. For those with less-severe disease, the risk of dying early was actually less than it was for people who didn't have the skin condition. Dr. Robert Kirsner, chair of dermatology at the University of Miami Miller School of Medicine, said that over the last decade or so, doctors have learned that people with psoriasis tend to be less healthy. "They are overweight, have diabetes mellitus, smoke, drink and have high cholesterol," he said. "These factors – as well as the presence of psoriasis itself – increases their risk for vascular disease and other poor ... Read more

Related support groups: Skin Rash, Smoking, Methotrexate, Psoriasis, Smoking Cessation, Plaque Psoriasis, Diabetes Mellitus, Tazorac, Dovonex, Soriatane, Taclonex, Acitretin, Calcipotriene, Enstilar, Vectical, Anthralin, Oxsoralen, Resorcinol, Oxsoralen-Ultra, Methoxsalen

Siliq Approved for Plaque Psoriasis

Posted 2 Mar 2017 by Drugs.com

THURSDAY, Feb. 16, 2017 – The injected drug Siliq (brodalumab) has been approved by the U.S. Food and Drug Administration to treat moderate-to-severe plaque psoriasis in adults. Siliq is approved for patients who've already failed to respond to other systemic therapies, the agency noted. The autoimmune disease – so-called because the immune system produces antibodies that attack the body's own tissues – causes thick, scaly patches of red skin. The drug is designed to inhibit the body's inflammatory response that plays a role in the development of plaque psoriasis, the FDA said in a news release. The disease occurs most often in people with a family history, usually between ages 15 and 35. Saliq was evaluated in clinical studies involving more than 4,300 people with moderate-to-severe plaque psoriasis. The most common side effects included joint pain, headache, fatigue, diarrhea, ... Read more

Related support groups: Methotrexate, Psoriasis, Plaque Psoriasis, Tazorac, Dovonex, Soriatane, Taclonex, Acitretin, Calcipotriene, Anthralin, Resorcinol, Oxsoralen, Enstilar, Vectical, Methoxsalen, Tazarotene, Oxsoralen-Ultra, Drithocreme, Methotrexate LPF Sodium, Psoriatec

FDA Approves Injectable Psoriasis Drug Siliq for Tough Cases

Posted 16 Feb 2017 by Drugs.com

THURSDAY, Feb. 16, 2017 – A new drug to treat tough cases of the skin condition psoriasis has won approval from the U.S. Food and Drug Administration. Valeant Pharmaceuticals' injectable drug Siliq (brodalumab) was approved for adults with moderate-to-severe psoriasis that isn't responding to other recommended treatments. However, the drug carries a warning about increased risk for suicidal behavior. Psoriasis is characterized by raised patches of red skin and flaking. The condition usually begins between ages 15 and 35 and is thought to be an autoimmune disorder, meaning the body mistakenly attacks healthy cells. "Moderate-to-severe plaque psoriasis can cause significant skin irritation and discomfort for patients, and today's approval provides patients with another treatment option for their psoriasis," said the FDA's Dr. Julie Beitz. Beitz is director of the Office of Drug ... Read more

Related support groups: Methotrexate, Psoriasis, Plaque Psoriasis, Tazorac, Dovonex, Soriatane, Taclonex, Acitretin, Calcipotriene, Anthralin, Resorcinol, Oxsoralen, Enstilar, Vectical, Methoxsalen, Tazarotene, Oxsoralen-Ultra, Drithocreme, Methotrexate LPF Sodium, Psoriatec

Health Tip: Caring for Psoriasis on Your Feet

Posted 4 Jan 2017 by Drugs.com

-- Psoriasis causes red, scaly, itchy plaques on the skin, including the feet. The American Podiatric Medical Association suggests these ways to soothe it: Moisturize your feet regularly. Choose a moisturizer that's hypoallergenic and non-irritating. Soak feet in an oatmeal bath. Ask your doctor about special light therapy. Avoid psoriasis triggers, such as alcohol and exposure to dry air. See a podiatrist if your foot psoriasis doesn't improve. Read more

Related support groups: Psoriasis, Plaque Psoriasis, Tazorac, Dovonex, Taclonex, Calcipotriene, Oxsoralen, Anthralin, Enstilar, Vectical, Foot Care, Resorcinol, Dritho-Scalp, Tazarotene, Psoriatec, Drithocreme, A-Fil, Psoriatic Arthropathy, Fabior, Resinol

Even Incomplete Steroid Treatment Helps Preemies: Study

Posted 10 Oct 2016 by Drugs.com

MONDAY, Oct. 10, 2016 – Even partial steroid treatment before birth can improve survival odds for extremely premature infants and reduce their risk of certain birth defects, a new study suggests. Steroids are standard therapy for pregnant women likely to give birth before 34 weeks of gestation. But the complete course of treatment takes at least 48 hours and doctors may decide not to begin treatment if premature delivery is imminent, explained researchers funded by the U.S. National Institutes of Health. But these new findings "suggest that starting steroid treatment promptly – even if the likelihood of completion is low – is beneficial when extremely premature birth is imminent," the researchers said. The investigators analyzed data from more than 6,100 extremely premature infants who were born between 22 and 27 weeks of pregnancy. They were followed for 18 to 22 months after birth. ... Read more

Related support groups: Betamethasone, Delivery, Premature Labor, Celestone, Betamethasone/Clotrimazole, Taclonex, Lotrisone, Betnovate, Beta-Val, Luxiq, Betaderm, Cesarean Section, Diprolene, Enstilar, Diprosone, Celestone Soluspan, Prematurity/Underweight in Infancy, Labor and Delivery including Augmentation, Adbeon, Betamethasone/Calcipotriene

Steroids Might Help More Than Just Very Premature Babies: Study

Posted 4 Feb 2016 by Drugs.com

THURSDAY, Feb. 4, 2016 – Giving steroids to pregnant women at risk for late preterm delivery may reduce the risk of severe respiratory problems in their babies, a new study finds. The study included more than 2,800 pregnant women with a high risk of late preterm delivery (34 to 36 weeks of pregnancy) who were randomly selected to receive two injections over 24 hours of either the steroid betamethasone or a placebo. The steroid is commonly used to prevent complications in babies born before 34 weeks of pregnancy. A full-term pregnancy is considered to be 40 weeks. Compared to babies born to mothers who received the placebo, babies born to mothers who received the steroid were much less likely to have severe respiratory complications shortly after birth, to require a long stay in the neonatal intensive care unit, or to need respiratory treatments. The findings were published Feb. 4 in ... Read more

Related support groups: Betamethasone, Delivery, Premature Labor, Labor Induction, Celestone, Betamethasone/Clotrimazole, Taclonex, Respiratory Tract Disease, Labor Pain, Lotrisone, Betnovate, Beta-Val, Luxiq, Betaderm, Diprolene, Diprosone, Enstilar, Celestone Soluspan, Prematurity/Underweight in Infancy, Labor and Delivery including Augmentation

Retail Prices of Dermatology Drugs Skyrocket

Posted 25 Nov 2015 by Drugs.com

WEDNESDAY, Nov. 25, 2015 – Patients using prescription creams, gels, sprays and pills for skin conditions may shell out substantially more at the pharmacy than they did just six years ago, a new study suggests. Between 2009 and 2015, retail prices of brand-name dermatologic drugs rose 401 percent, on average, study authors reported Nov. 25 in JAMA Dermatology. Even generics have succumbed to price inflation, up 279 percent between 2011 and 2014, based on the drugs surveyed. Price increases for skin treatments far outpaced the general inflation rate of 11 percent during the six-year study period, the researchers said. "Cancer drugs were the worst in terms of the numbers" – up 1,240 percent or nearly $11,000 over the six-year study period – primarily because of two medicines, said Dr. Steven Rosenberg, voluntary professor of dermatology at the University of Miami Miller School of ... Read more

Related support groups: Monistat, RID, Monistat 3, Eczema, Monistat 7, Voltaren Gel, Dermatitis, Clobetasol, Contact Dermatitis, Mupirocin, Epiduo, Sulfur, Drysol, Therapeutic, Efudex, Basal Cell Carcinoma, Maintain, Bactroban, Retin-A, Silver

LEO Pharma Announces U.S. Approval of Enstilar Foam (calcipotriene/betamethasone dipropionate) for Plaque Psoriasis

Posted 21 Oct 2015 by Drugs.com

Ballerup, Denmark 19 October, 2015: LEO Pharma announced today that the U.S. Food and Drug Administration (FDA) has approved Enstilar (calcipotriene/betamethasone dipropionate 50 micrograms/g / 0,5 mg/g) Foam for the treatment of psoriasis vulgaris in patients 18 years of age or older in the United States.1 Enstilar is a once-daily, alcohol-free topical treatment.1 “We are very pleased by the U.S. approval of Enstilar and believe it will provide patients with the type of treatment option that they are looking for,” said Gitte Aabo, President and CEO of LEO Pharma. “At LEO Pharma, we are committed to providing patients with innovative, new solutions and we believe the foam formulation of Enstilar can help patients living with psoriasis.” Enstilar was developed to treat patients with psoriasis vulgaris2,3 – the most common clinical form of psoriasis.4 The U.S. approval of Enstilar was ... Read more

Related support groups: Psoriasis, Plaque Psoriasis, Enstilar, Betamethasone/Calcipotriene

Worse Psoriasis, Less Healthy Arteries, Study Finds

Posted 8 Oct 2015 by Drugs.com

THURSDAY, Oct. 8, 2015 – The skin disorder psoriasis appears linked with artery inflammation, raising the odds for heart disease, a new study says. "As the amount of psoriasis increases, the amount of blood vessel inflammation increases," said senior investigator Dr. Nehal Mehta, a clinical investigator with the U.S. National Heart, Lung, and Blood Institute. His team also found that even mild psoriasis may indicate an increased risk for heart attack and stroke. Just one psoriasis skin patch, or plaque, "might be biologically active, causing low-grade inflammation and starting a cascade, speeding up their blood vessel disease," Mehta said. "People really should know that psoriasis is not just a cosmetic disease," he added. However, these study findings only show an association between psoriasis and blood vessel inflammation, not a direct cause-and-effect relationship, Mehta said. His ... Read more

Related support groups: Methotrexate, Psoriasis, Inflammatory Conditions, Plaque Psoriasis, Coronary Artery Disease (CAD), Tazorac, Acute Coronary Syndrome, Dovonex, Soriatane, Taclonex, Acitretin, Calcipotriene, Oxsoralen, Resorcinol, Acute Coronary Syndrome - Prophylaxis, Anthralin, Vectical, Methotrexate LPF Sodium, Tazarotene, Dritho-Scalp

Ask a Question

Further Information

Related Condition Support Groups

Plaque Psoriasis, Psoriasis

Related Drug Support Groups

Taclonex, Enstilar, Dovobet, Taclonex Scalp

Betamethasone / Calcipotriene Patient Information at Drugs.com